Concepedia

Ako Ishihara

AI

Statistics

Publications

12

Citations

1.4K

H-Index

12

Active since

2017

Affiliations

University of Chicago(Current)

École Polytechnique Fédérale de Lausanne

University of Illinois Chicago

Imperial College London

Osaka Prefecture University

Ako Ishihara is an author at University of Chicago specializing in immunology, cancer immunotherapy, and oncology.

ORCID

Publications per year

2017–2020

12

Publications

12

Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing

Jun Ishihara, Ako Ishihara, Kazuto Fukunaga et al. · Nature Communications · 2018 · 237 citations · Full text

, , +17

Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours

Aslan Mansurov, Jun Ishihara, Peyman Hosseinchi et al. · Nature Biomedical Engineering · 2020 · 232 citations · Full text

, , +16

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Jun Ishihara, Ako Ishihara, Koichi Sasaki et al. · Science Translational Medicine · 2019 · 186 citations · Full text

, , +17

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events

Jun Ishihara, Kazuto Fukunaga, Ako Ishihara et al. · Science Translational Medicine · 2017 · 156 citations · Full text

, , +17

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing

Jun Ishihara, Ako Ishihara, Richard Starke et al. · Blood · 2019 · 132 citations · Full text

, , +14

1–5 of 12